Skip to content
AASLD Family of Websites: Liver Fellow Network
AASLD.org AASLD Foundation LiverLearning Career Center Journals The Liver Meeting HCV Guidelines
AASLD Logo
AASLD Logo

LFN Main Navigation

  • Topics
    Acute Liver Failure Alcohol-Associated Liver Disease Autoimmune Hepatitis Career Development and Mentorship Cholestatic Liver Disease Complications of Liver Disease and Portal Hypertension Drug-Induced Liver Disease HepMadness Inherited Disorders Liver Anatomy, Development, and Physiology Liver Infections Liver Physiology Liver Related Infections MASLD/MASH Neoplasms of the Liver Pathology Pediatrics Pregnancy-Related Liver Disease Symptoms and Clinical Presentation of Liver Disease and Portal HTN Systemic Conditions with Hepatic Manifestations Transplantation and Surgery Vascular Viral Hepatitis
  • Core Series
    Back to Basics Clinical Pearls Webinars Evidence Corner Pathology Pearls Podcast The Why? Series Tools of the Trade View All Core Series Practice Questions
  • Tweetorials
  • About
  • Core Series
  • Evidence Corner
  • Safety Of Naltrexone Use In Patients With Liver Disease

Safety of Naltrexone Use in Patients with Liver Disease

September 25, 2023

Jonathan Lin

Share

Copy Link Twitter Facebook

https://journals.lww.com/hepcomm/fulltext/2022/12000/naltrexone_for_alc…

HepMadness

Share

Copy Link Twitter Facebook

Written By:

Jonathan Lin

Related Content

Living with Cirrhosis: symptom insights and innovations

October 16, 2024

Post Liver Transplant Complications

October 16, 2024

Bridging Gaps in Guideline-Directed Care

October 16, 2024

AASLD LFN Logo

Follow Us

Disclaimer & Privacy Policy

© 2025 American Association for the Study of Liver Diseases